Cargando…
HIF-1α in myocardial ischemia-reperfusion injury
Myocardial ischemia-reperfusion injury (MIRI) is a severe injury to the ischemic myocardium following the recovery of blood flow. Currently, there is no effective treatment for MIRI in clinical practice. Over the past two decades, biological studies of hypoxia and hypoxia-inducible factor-1α (HIF-1α...
Autores principales: | Zheng, Jie, Chen, Peier, Zhong, Jianfeng, Cheng, Yu, Chen, Hao, He, Yuan, Chen, Can |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7974458/ https://www.ncbi.nlm.nih.gov/pubmed/33760122 http://dx.doi.org/10.3892/mmr.2021.11991 |
Ejemplares similares
-
HIF-1α Signaling Activation by Post-Ischemia Treatment with Astragaloside IV Attenuates Myocardial Ischemia-Reperfusion Injury
por: Si, Jingwen, et al.
Publicado: (2014) -
MicroRNA-138 attenuates myocardial ischemia reperfusion injury through inhibiting mitochondria-mediated apoptosis by targeting HIF1-α
por: Liu, Yan, et al.
Publicado: (2019) -
Ube2s-stabilized β-catenin protects against myocardial ischemia/reperfusion injury by activating HIF-1α signaling
por: Chen, Xi, et al.
Publicado: (2020) -
The role of HIFs in ischemia-reperfusion injury
por: Howell, Neil J, et al.
Publicado: (2014) -
Inhibiting miR-155 protects against myocardial ischemia/reperfusion injury via targeted regulation of HIF-1α in rats
por: Chen, Jian-Guo, et al.
Publicado: (2019)